Lu Diao
Impact in
-
- Immunotherapy and Immune Responses
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 4
- Gut microbiota and health 2
-
- Nanoplatforms for cancer theranostics 6
- Co-authors
- Mi Liu (11 shared papers)Jin Tao (6 shared papers)Ao Shen (3 shared papers)Yang Zhang (1 shared paper)Dong Xia (2 shared papers)Fengfeng Mo (3 shared papers)Xinming Chen (2 shared papers)Wenfei He (1 shared paper)
In The Last Decade
Lu Diao
23 papers receiving 557 citations
Peers
Comparison fields: 5 of 87
- Immunology 194
- Biomaterials 86
- Molecular Medicine 24
- Biomedical Engineering 196
- Oncology 93
Countries citing papers authored by Lu Diao
This map shows the geographic impact of Lu Diao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Diao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Diao more than expected).
Fields of papers citing papers by Lu Diao
This network shows the impact of papers produced by Lu Diao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Diao. The network helps show where Lu Diao may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Diao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 105 | |
| 2 | 2020 | 86 | |
| 3 | 2023 | 86 | |
| 4 | 2019 | 40 | |
| 5 | 2020 | 34 | |
| 6 | 2010 | 33 | |
| 7 | 2009 | 31 | |
| 8 | 2018 | 25 | |
| 9 | 2019 | 19 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 18 | |
| 12 | 2023 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2009 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2025 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2025 | 2 | |
| 20 | [Expression of apoptosis and proliferation related genes in carcinogenesis of lung squamous cell carcinoma in rats]. | 2003 | 2 |
About Lu Diao
Lu Diao is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Immunology and Oncology, having authored 26 papers that have together received 561 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Immunotherapy and Immune Responses (6 papers), Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer Research and Treatments (2 papers), Gut microbiota and health (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Advanced Nanomaterials in Catalysis (2 papers). The work is most often cited by research in Immunology (194 citations), Biomaterials (86 citations), Molecular Medicine (24 citations), Biomedical Engineering (196 citations) and Oncology (93 citations). Lu Diao has collaborated with scholars based in China, Australia and Canada. Frequent co-authors include Mi Liu, Jin Tao, Ao Shen, Yang Zhang, Dong Xia, Fengfeng Mo, Xinming Chen, Wenfei He, Ying Hu and Yiqi Wang. Their work appears in journals such as Advanced Science, iScience, RSC Advances, International Journal of Nanomedicine and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.